Baltimore, MD and Philadelphia, PA September 7, 2006
Lentigen Corporation announced today the signing of a second collaborative research agreement (CRA) with the University of Pennsylvania. Under the terms of this agreement, Lentigen will Read More...
BALTIMORE, MD and LAFAYETTE, CO, August 30, 2006
Lentigen Corporation
and Dharmacon, Inc. announced today a multi-year collaboration to develop and
manufacture lentiviral expression reagents to deliver short hairpin RNA (shRNA)
expression vectors int Read More...
Baltimore, MD and Philadelphia, PA
July 27, 2006
Lentigen Corporation announced today the signing of a collaborative research agreement (CRA) with the University of Pennsylvania. Under the terms of this agreement, Lentigen will be working with James Riley, P Read More...
Baltimore, Maryland and Edgewood, Maryland May 30, 2006
Lentigen Corporation announced today they have entered into a Cooperative Research and Development Agreement (CRADA) with the US Army Edgewood Chemical Biological Center (ECBC) whereby Le Read More...
Baltimore, MD, May 22, 2006
Lentigen Corporation, a privately held biotechnology
company focused on the manufacturing and development of lentiviral vectors, announced
today that it has been named one of the top 100 innovators by Red Herring Magazine Read More...
Baltimore, Maryland and Philadelphia, Pennsylvania May 19, 2006
Lentigen Corporation announced today an exclusive, worldwide licensing agreement with the University of Pennsylvania relating to lentiviral vector technology.
The intellectual property, which was develo Read More...
Baltimore, Maryland February 2, 2006
Lentigen Corporation announced today that
the State of Maryland has recognized it as one of the recipients of the first Maryland
Technology Champions Awards. Maryland Governor Robert L. Ehrlich, Jr. and Secretary
Read More...
Baltimore, Maryland and Moscow, Russia January 30, 2006
Lentigen Corporation and Evrogen JSC announced today a licensing agreement whereby Lentigen will obtain access to certain novel fluorescent protein technologies. Such technologies will enable th Read More...
Lentigen Gains Exclusive, World-Wide License
to Multisubstrate Kinase Gene Technology
Baltimore, Maryland and Lyngby, Denmark January 9, 2006
Lentigen Corporation
and ZGene A/S announced today they have entered into Read More...
Baltimore, MD, December 13, 2005
Lentigen Corporation, a privately held
biotechnology company focused on the manufacturing and development of lentiviral
vectors, announced that the company has secured financing through the state of
Read More...
